StockTipsArenaBeta

BUY Alkem Laboratories Limited — ICICI Securities

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)19 Sept 2025via Institutional / Brokerage Research

Entry₹5,541.5Inferred
Target₹6,400
Total upside +15.49% (call closed)
Stop lossNot given
At expiry₹5,466.518 Sept 2026, 3:30 pm
Expired-1.35%auction close
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 7 active Long-term calls on ALKEMSee 212 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
16 supporting7 neutral3 opposing
Supports the BUY call (16)

Alkem Laboratories Limited has launched NeuCeno (cenobamate) for treating partial-onset seizures in adult patients.

BSE · Company Update·16 Sept · 2d ago

(opens in new tab)

Alkem Laboratories has launched Renocia ExoTM, a hair growth serum based on patented Ginsenoside Exosomes, marking a significant product introduction in India.

BSE · Company Update·8 Sept · 1w ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 3w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Aug · 3w ago

Neutral / worth noting (7)

Broker’s Call: Alkem Laboratories (Buy)

NewsHbl·1 Sept · 2w ago

(opens in new tab)

Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit

NewsNdtv-Profit·21 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (3)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·17 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from ICICI Securities

Every call and its outcome